{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:29Z","timestamp":1794047429530,"version":"4.8.0"},"reference-count":53,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>RNA-binding proteins (RBP) have emerged as essential regulators that control gene expression and modulate multiple cancer traits. T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy derived from transformation of T-cell progenitors that normally undergo discrete steps of differentiation in the thymus. The implications of essential RBP during T-cell neoplastic transformation remain largely unclear. Systematic evaluation of RBP identifies RNA helicase DHX15, which facilitates the disassembly of the spliceosome and release of lariat introns, as a T-ALL dependency factor. Functional analysis using multiple murine T-ALL models demonstrates the essential importance of DHX15 in tumor cell survival and leukemogenesis. Moreover, single-cell transcriptomics reveals that DHX15 depletion in T-cell progenitors hinders burst proliferation during the transition from doublenegative to double-positive cells (CD4-CD8- to CD4+CD8+). Mechanistically, abrogation of DHX15 perturbs RNA splicing and leads to diminished levels of SLC7A6 and SLC38A5 transcripts due to intron retention, thereby suppressing glutamine import and mTORC1 activity. We further propose a DHX15 signature modulator drug ciclopirox and demonstrate that it has prominent anti-T-ALL efficacy. Collectively, our data highlight the functional contribution of DHX15 to leukemogenesis through regulation of established oncogenic pathways. These findings also suggest a promising therapeutic approach, i.e., splicing perturbation by targeting spliceosome disassembly, may achieve considerable anti-tumor efficacy.<\/jats:p>","DOI":"10.3324\/haematol.2022.282066","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:30:51Z","timestamp":1677727851000},"page":"2029-2043","source":"Crossref","is-referenced-by-count":9,"title":["RNA helicase DHX15 exemplifies a unique dependency in acute leukemia"],"prefix":"10.3324","volume":"108","author":[{"given":"Hao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Palhais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Taghon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"50130","doi-asserted-by":"crossref","unstructured":"Yang Q, Jeremiah Bell J, Bhandoola A. T-cell lineage determination. Immunol Rev. 2010; 238(1):12-22.","DOI":"10.1111\/j.1600-065X.2010.00956.x"},{"key":"50131","doi-asserted-by":"crossref","unstructured":"Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012; 122(10):3398-3406.","DOI":"10.1172\/JCI61269"},{"key":"50132","doi-asserted-by":"crossref","unstructured":"Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008; 371(9617):1030-1043.","DOI":"10.1016\/S0140-6736(08)60457-2"},{"key":"50133","doi-asserted-by":"crossref","unstructured":"Litzow MR, Ferrando AA. How I treat T-cell acute lymphoblastic leukemia in adults. Blood. 2015; 126(7):833-841.","DOI":"10.1182\/blood-2014-10-551895"},{"key":"50134","doi-asserted-by":"crossref","unstructured":"Cordo V, van der Zwet JCG, Cant\u00e9-Barrett K, Pieters R, Meijerink JPP. T-cell acute lymphoblastic leukemia: a roadmap to targeted therapies. Blood Cancer Discov. 2021; 2(1):19-31.","DOI":"10.1158\/2643-3230.BCD-20-0093"},{"key":"50135","doi-asserted-by":"crossref","unstructured":"Elcheva IA, Spiegelman VS. Targeting RNA-binding proteins in acute and chronic leukemia. Leukemia. 2021; 35(2):360-376.","DOI":"10.1038\/s41375-020-01066-4"},{"key":"50136","doi-asserted-by":"crossref","unstructured":"Chen S, Benbarche S, Abdel-Wahab O. Splicing factor mutations in hematologic malignancies. Blood. 2021; 138(8):599-612.","DOI":"10.1182\/blood.2019004260"},{"key":"50137","doi-asserted-by":"crossref","unstructured":"Lee SC, Abdel-Wahab O. Therapeutic targeting of splicing in cancer. Nat Med. 2016; 22(9):976-986.","DOI":"10.1038\/nm.4165"},{"key":"50138","doi-asserted-by":"crossref","unstructured":"Bohnsack KE, Kanwal N, Bohnsack MT. Prp43\/DHX15 exemplify RNA helicase multifunctionality in the gene expression network. Nucleic Acids Res. 2022; 50(16):9012-9022.","DOI":"10.1093\/nar\/gkac687"},{"key":"50139","doi-asserted-by":"crossref","unstructured":"Arenas JE, Abelson JN. Prp43: an RNA helicase-like factor involved in spliceosome disassembly. Proc Natl Acad Sci U S A. 1997; 94(22):11798-11802.","DOI":"10.1073\/pnas.94.22.11798"},{"key":"50140","doi-asserted-by":"crossref","unstructured":"Tsai RT, Fu RH, Yeh FL. Spliceosome disassembly catalyzed by Prp43 and its associated components Ntr1 and Ntr2. Genes Dev. 2005; 19(24):2991-3003.","DOI":"10.1101\/gad.1377405"},{"key":"50141","doi-asserted-by":"crossref","unstructured":"Martin A, Schneider S, Schwer B. Prp43 is an essential RNA-dependent ATPase required for release of lariat-intron from the spliceosome. J Biol Chem. 2002; 277(20):17743-17750.","DOI":"10.1074\/jbc.M200762200"},{"key":"50142","doi-asserted-by":"crossref","unstructured":"Wan R, Yan C, Bai R, Lei J, Shi Y. Structure of an intron lariat spliceosome from Saccharomyces cerevisiae. Cell. 2017; 171(1):120-132.","DOI":"10.1016\/j.cell.2017.08.029"},{"key":"50143","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhan X, Yan C. Structures of the human spliceosomes before and after release of the ligated exon. Cell Res. 2019; 29(4):274-285.","DOI":"10.1038\/s41422-019-0143-x"},{"key":"50144","doi-asserted-by":"crossref","unstructured":"Ito S, Koso H, Sakamoto K, Watanabe S. RNA helicase DHX15 acts as a tumour suppressor in glioma. Br J Cancer. 2017; 117(9):1349-1359.","DOI":"10.1038\/bjc.2017.273"},{"key":"50145","doi-asserted-by":"crossref","unstructured":"Jing Y, Nguyen MM, Wang D. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor. Oncogene. 2018; 37(5):638-650.","DOI":"10.1038\/onc.2017.371"},{"key":"50146","doi-asserted-by":"crossref","unstructured":"Li X, Gounari F, Protopopov A, Khazaie K, von Boehmer H. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med. 2008; 205(12):2851-2861.","DOI":"10.1084\/jem.20081561"},{"key":"50147","doi-asserted-by":"crossref","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018; 19(1):15.","DOI":"10.1186\/s13059-017-1382-0"},{"key":"50148","doi-asserted-by":"crossref","unstructured":"Traag VA, Waltman L, van Eck NJ. From Louvain to Leiden: guaranteeing well-connected communities. Sci Rep. 2019; 9(1):5233.","DOI":"10.1038\/s41598-019-41695-z"},{"key":"50149","doi-asserted-by":"crossref","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A. ETV6 mutations in early immature human T cell leukemias. J Exp Med. 2011; 208(13):2571-2579.","DOI":"10.1084\/jem.20112239"},{"key":"50150","doi-asserted-by":"crossref","unstructured":"Wang E, Lu SX, Pastore A. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019; 35(3):369-384.","DOI":"10.1016\/j.ccell.2019.01.010"},{"key":"50151","doi-asserted-by":"crossref","unstructured":"Zhou Y, Han C, Wang E. Posttranslational regulation of the exon skipping machinery controls aberrant splicing in leukemia. Cancer Discov. 2020; 10(9):1388-1409.","DOI":"10.1158\/2159-8290.CD-19-1436"},{"key":"50152","doi-asserted-by":"crossref","unstructured":"Verboom K, Van Loocke W, Volders PJ. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing. Haematologica. 2018; 103(12):e585-e589.","DOI":"10.3324\/haematol.2018.190587"},{"key":"50153","doi-asserted-by":"crossref","unstructured":"Roels J, Kuchmiy A, De Decker M. Distinct and temporary-restricted epigenetic mechanisms regulate human \u03b1\u03b2 and y\u00f6 T cell development. Nat Immunol. 2020; 21(10):1280-1292.","DOI":"10.1038\/s41590-020-0747-9"},{"key":"50154","doi-asserted-by":"crossref","unstructured":"Homminga I, Pieters R, Langerak AW. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011; 19(4):484-497.","DOI":"10.1016\/j.ccr.2011.02.008"},{"key":"50155","doi-asserted-by":"crossref","unstructured":"Haferlach T, Kohlmann A, Wieczorek L. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol. 2010; 28(15):2529-2537.","DOI":"10.1200\/JCO.2009.23.4732"},{"key":"50156","doi-asserted-by":"crossref","unstructured":"Barretina J, Caponigro G, Stransky N. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-607.","DOI":"10.1038\/nature11003"},{"key":"50157","doi-asserted-by":"crossref","unstructured":"Mansour MR, Abraham BJ, Anders L. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 2014; 346(6215):1373-1377.","DOI":"10.1126\/science.1259037"},{"key":"50158","doi-asserted-by":"crossref","unstructured":"Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature. 1988; 335(6193):835-837.","DOI":"10.1038\/335835a0"},{"key":"50159","doi-asserted-by":"crossref","unstructured":"Gocho Y, Liu J, Hu J. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nat Cancer. 2021; 2(3):284-299.","DOI":"10.1038\/s43018-020-00167-4"},{"key":"50160","doi-asserted-by":"crossref","unstructured":"Yang L, Chen F, Zhu H. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia. Nat Commun. 2021; 12(1):3708.","DOI":"10.1038\/s41467-021-24044-5"},{"key":"50161","doi-asserted-by":"crossref","unstructured":"Zhu H, Dong B, Zhang Y. Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia. Blood Sci. 2022; 4(1):16-28.","DOI":"10.1097\/BS9.0000000000000102"},{"key":"50162","doi-asserted-by":"crossref","unstructured":"Seki M, Kimura S, Isobe T. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet. 2017; 49(8):1274-1281.","DOI":"10.1038\/ng.3900"},{"key":"50163","doi-asserted-by":"crossref","unstructured":"Li Y Li K, Zhu L. Development of double-positive thymocytes at single-cell resolution. Genome Med. 2021; 13(1):49.","DOI":"10.1186\/s13073-021-00861-7"},{"key":"50164","doi-asserted-by":"crossref","unstructured":"Zhou W, Yui MA, Williams BA. Single-cell analysis reveals regulatory gene expression dynamics leading to lineage commitment in early T cell development. Cell Syst. 2019; 9(4):321-337.","DOI":"10.1016\/j.cels.2019.09.008"},{"key":"50165","doi-asserted-by":"crossref","unstructured":"Zhang J, Huang J, Xu K. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer. Proc Natl Acad Sci U S A. 2022; 119(49):e2216712119.","DOI":"10.1073\/pnas.2216712119"},{"key":"50166","doi-asserted-by":"crossref","unstructured":"Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E. Mol Cell Biol. 2004; 24(1):200-216.","DOI":"10.1128\/MCB.24.1.200-216.2004"},{"key":"50167","doi-asserted-by":"crossref","unstructured":"Hoshii T, Kasada A, Hatakeyama T. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells. Proc Natl Acad Sci U S A. 2014; 111(10):3805-3810.","DOI":"10.1073\/pnas.1320265111"},{"key":"50168","doi-asserted-by":"crossref","unstructured":"Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009; 10(5):307-318.","DOI":"10.1038\/nrm2672"},{"key":"50169","doi-asserted-by":"crossref","unstructured":"Jewell JL, Kim YC, Russell RC. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science. 2015; 347(6218):194-198.","DOI":"10.1126\/science.1259472"},{"key":"50170","doi-asserted-by":"crossref","unstructured":"Dur\u00e1n RV, Oppliger W, Robitaille AM. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell. 2012; 47(3):349-358.","DOI":"10.1016\/j.molcel.2012.05.043"},{"key":"50171","doi-asserted-by":"crossref","unstructured":"Garami A, Zwartkruis FJ, Nobukuni T. Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell. 2003; 11(6):1457-1466.","DOI":"10.1016\/S1097-2765(03)00220-X"},{"key":"50172","doi-asserted-by":"crossref","unstructured":"Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003; 17(15):1829-1834.","DOI":"10.1101\/gad.1110003"},{"key":"50173","doi-asserted-by":"crossref","unstructured":"Ge D, Han L, Huang S. Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells. Autophagy. 2014; 10(6):957-971.","DOI":"10.4161\/auto.28363"},{"key":"50174","doi-asserted-by":"crossref","unstructured":"Subramanian A, Narayan R, Corsello SM. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017; 171(6):1437-1452.","DOI":"10.1016\/j.cell.2017.10.049"},{"key":"50175","doi-asserted-by":"crossref","unstructured":"Sehgal VN. Ciclopirox: a new topical pyrodonium antimycotic agent. A double-blind study in superficial dermatomycoses. Br J Dermatol. 1976; 95(1):83-88.","DOI":"10.1111\/j.1365-2133.1976.tb15537.x"},{"key":"50176","doi-asserted-by":"crossref","unstructured":"Glisovic T, Bachorik JL, Yong J, Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008; 582(14):1977-1986.","DOI":"10.1016\/j.febslet.2008.03.004"},{"key":"50177","doi-asserted-by":"crossref","unstructured":"Xiao R, Chen JY, Liang Z. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell. 2019; 178(1):107-121.","DOI":"10.1016\/j.cell.2019.06.001"},{"key":"50178","doi-asserted-by":"crossref","unstructured":"Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer. 2017; 3(7):506-528.","DOI":"10.1016\/j.trecan.2017.05.003"},{"key":"50179","doi-asserted-by":"crossref","unstructured":"Su H, Hu J, Huang L. SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival. Nat Commun. 2018; 9(1):4281.","DOI":"10.1038\/s41467-018-06523-4"},{"key":"50180","doi-asserted-by":"crossref","unstructured":"Clappier E, Cuccuini W, Kalota A. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood. 2007; 110(4):1251-1261.","DOI":"10.1182\/blood-2006-12-064683"},{"key":"50181","doi-asserted-by":"crossref","unstructured":"Lahortiga I, De Keersmaecker K, Van Vlierberghe P. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet. 2007; 39(5):593-595.","DOI":"10.1038\/ng2025"},{"key":"50182","doi-asserted-by":"crossref","unstructured":"Han C, Khodadadi-Jamayran A, Lorch AH. SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia. Sci Adv. 2022; 8(3):eabj8357.","DOI":"10.1126\/sciadv.abj8357"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282066\/75431","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282066\/75867","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11003\/75431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:38Z","timestamp":1794045818000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282066","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,2]]}}}